Ditchcarbon
  • Customers
  1. Organizations
  2. C2N Diagnostics, LLC
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

C2N Diagnostics, LLC

Company website

C2N Diagnostics, LLC, headquartered in the United States, is a pioneering company in the field of diagnostic testing, particularly focused on neurodegenerative diseases. Founded in 2012, C2N has established itself as a leader in the development of innovative biomarkers that aid in the early detection and management of conditions such as Alzheimer’s disease. The company’s flagship products, including the PrecivityAD™ test, are designed to provide clinicians with critical insights into patients' cognitive health, setting C2N apart in the competitive diagnostics landscape. With a commitment to advancing precision medicine, C2N Diagnostics has achieved significant milestones, including partnerships with leading research institutions and recognition for its contributions to the field. As a trusted name in neurodiagnostics, C2N continues to enhance patient care through its cutting-edge solutions.

DitchCarbon Score

How does C2N Diagnostics, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

C2N Diagnostics, LLC's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.

23%

Let us know if this data was useful to you

C2N Diagnostics, LLC's reported carbon emissions

C2N Diagnostics, LLC, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that C2N Diagnostics may not yet have established a formal framework for measuring or reducing its carbon footprint. In the context of the diagnostics industry, many companies are increasingly adopting science-based targets and sustainability initiatives to address climate change. However, without specific commitments or data, C2N Diagnostics remains outside this trend. As the industry evolves, it may be beneficial for the company to consider implementing strategies to monitor and reduce its environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. C2N Diagnostics, LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for C2N Diagnostics, LLC is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

C2N Diagnostics, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

MESO SCALE DIAGNOSTICS LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Sigma-Aldrich Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Seer, Inc.

US
•
Research and development services (73)
Updated 14 days ago

Bio-Techne

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Roche Holding AG

CH
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Quanterix Corporation

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy